SAFETY AND EFFICACY CONCERNS RAISED BY THE FDA, AUSTRALIAN GOVERNMENT, AND BIG PHARMA AFTER FIVE DIE ON COMPOUNDED GLP-1 DRUGS, AND OTHERS REPORT SERIOUS SIDE EFFECTS Despite allowing compounding, the FDA has expressed concerns about GLP-1 knockoffs
The most practical concern for any breastfeeding mother considering GLP-1 therapy is whether she can maintain adequate nutrition while experiencing appetite suppression
GHK-Cu works on all hair textures, straight, curly, fine, or coarse, as its primary action is at the follicle level, not the hair shaft
During the consultation, the provider reviews your health information, discusses treatment options, explains the risks and benefits of compounded tirzepatide versus other GLP-1 options , and determines whether you are a good candidate for treatment
Cloudiness, difficulty dissolving, or visible particles suggest degradation
The increasing evidence that altered gut microbiota correlate with non-motor features of PD rests on the premise of the need for more evidence to be generated for possible therapeutic strategies to be unveiled